Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators

Abstract Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder, and critically ill patients with T2DM in intensive care unit (ICU) have an increased risk of mortality. In this study, we investigated the relationship between nine inflammatory indicators and prognosis in critically ill patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin Liu, Yan-Bo Zhao, Zhuo-Ting Cheng, Ya-Hui Li, Yang Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87731-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571772173549568
author Lin Liu
Yan-Bo Zhao
Zhuo-Ting Cheng
Ya-Hui Li
Yang Liu
author_facet Lin Liu
Yan-Bo Zhao
Zhuo-Ting Cheng
Ya-Hui Li
Yang Liu
author_sort Lin Liu
collection DOAJ
description Abstract Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder, and critically ill patients with T2DM in intensive care unit (ICU) have an increased risk of mortality. In this study, we investigated the relationship between nine inflammatory indicators and prognosis in critically ill patients with T2DM to provide a clinical reference for assessing the prognosis of patients admitted to the ICU. Critically ill patients with T2DM were extracted from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and divided into training and testing sets (7:3 ratio). An external validation cohort was collected from a single center in China using identical criteria. Logistic and Cox regression analyses were used to evaluate the relationship between nine inflammatory indicators and ICU, 30-day, and 90-day mortality rates. Significant predictive variables were chosen using least absolute shrinkage selection operator (LASSO) regression from logistic regression results, and a prognostic prediction model was built with multivariate logistic regression. The model was validated in both test and external validation sets. A total of 4,783 patients were included for model development and testing; an additional 204 served as the external validation set. The levels of eight inflammatory indicators were significantly correlated with short-term prognosis in critically ill patients with T2DM (P < 0.05 for all). The prediction model showed excellent discrimination performance, with AUC values of 0.825 (95% CI, 0.785–0.864) in the test set and 0.741 (95% CI, 0.630–0.851) in the external validation set. Calibration curves demonstrated strong consistency in both sets. In addition, decision curve analysis showed a net clinical benefit within 1–60% threshold probability in the test set and 10–41% threshold probability in the external validation set. Eight inflammatory indicators were identified as independent risk factors for prognosis in critically ill patients with T2DM. The prediction model showed promising performance in both internal and external validation cohorts, highlighting its potential as a valuable tool for early risk stratification and prediction of the outcomes of personalized treatment strategies in ICU settings.
format Article
id doaj-art-1281eeb5c1314abe8fa3e29b7e6f46b0
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1281eeb5c1314abe8fa3e29b7e6f46b02025-02-02T12:17:30ZengNature PortfolioScientific Reports2045-23222025-01-0115112010.1038/s41598-025-87731-zDevelopment and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicatorsLin Liu0Yan-Bo Zhao1Zhuo-Ting Cheng2Ya-Hui Li3Yang Liu4Department of Emergency and Critical Care Center, Renmin Hospital, Hubei University of MedicineDepartment of Emergency and Critical Care Center, Renmin Hospital, Hubei University of MedicineSchool of Nursing, Hubei University of MedicineDivision of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Huazhong University of Science and TechnologyCenter of Health Administration and Development Studies, Hubei University of MedicineAbstract Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder, and critically ill patients with T2DM in intensive care unit (ICU) have an increased risk of mortality. In this study, we investigated the relationship between nine inflammatory indicators and prognosis in critically ill patients with T2DM to provide a clinical reference for assessing the prognosis of patients admitted to the ICU. Critically ill patients with T2DM were extracted from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and divided into training and testing sets (7:3 ratio). An external validation cohort was collected from a single center in China using identical criteria. Logistic and Cox regression analyses were used to evaluate the relationship between nine inflammatory indicators and ICU, 30-day, and 90-day mortality rates. Significant predictive variables were chosen using least absolute shrinkage selection operator (LASSO) regression from logistic regression results, and a prognostic prediction model was built with multivariate logistic regression. The model was validated in both test and external validation sets. A total of 4,783 patients were included for model development and testing; an additional 204 served as the external validation set. The levels of eight inflammatory indicators were significantly correlated with short-term prognosis in critically ill patients with T2DM (P < 0.05 for all). The prediction model showed excellent discrimination performance, with AUC values of 0.825 (95% CI, 0.785–0.864) in the test set and 0.741 (95% CI, 0.630–0.851) in the external validation set. Calibration curves demonstrated strong consistency in both sets. In addition, decision curve analysis showed a net clinical benefit within 1–60% threshold probability in the test set and 10–41% threshold probability in the external validation set. Eight inflammatory indicators were identified as independent risk factors for prognosis in critically ill patients with T2DM. The prediction model showed promising performance in both internal and external validation cohorts, highlighting its potential as a valuable tool for early risk stratification and prediction of the outcomes of personalized treatment strategies in ICU settings.https://doi.org/10.1038/s41598-025-87731-zComposite inflammatory indicatorsT2DMPrediction modelMIMIC database.
spellingShingle Lin Liu
Yan-Bo Zhao
Zhuo-Ting Cheng
Ya-Hui Li
Yang Liu
Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
Scientific Reports
Composite inflammatory indicators
T2DM
Prediction model
MIMIC database.
title Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
title_full Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
title_fullStr Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
title_full_unstemmed Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
title_short Development and validation of a prognostic model for critically ill type 2 diabetes patients in ICU based on composite inflammatory indicators
title_sort development and validation of a prognostic model for critically ill type 2 diabetes patients in icu based on composite inflammatory indicators
topic Composite inflammatory indicators
T2DM
Prediction model
MIMIC database.
url https://doi.org/10.1038/s41598-025-87731-z
work_keys_str_mv AT linliu developmentandvalidationofaprognosticmodelforcriticallyilltype2diabetespatientsinicubasedoncompositeinflammatoryindicators
AT yanbozhao developmentandvalidationofaprognosticmodelforcriticallyilltype2diabetespatientsinicubasedoncompositeinflammatoryindicators
AT zhuotingcheng developmentandvalidationofaprognosticmodelforcriticallyilltype2diabetespatientsinicubasedoncompositeinflammatoryindicators
AT yahuili developmentandvalidationofaprognosticmodelforcriticallyilltype2diabetespatientsinicubasedoncompositeinflammatoryindicators
AT yangliu developmentandvalidationofaprognosticmodelforcriticallyilltype2diabetespatientsinicubasedoncompositeinflammatoryindicators